Gossamer Bio, Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Faheem Hasnain (CEO) and Bryan Giraudo (CFO/COO) issued standard Sarbanes-Oxley Section 302 and 906 certifications on August 13, 2026 for the quarter ended June 30, 2026, certifying that the 10-Q filing contains no material misstatements, that financial statements fairly present the company's condition, and that disclosure and internal controls are effective. No material changes, deficiencies, or fraud were reported.
Why this rating
Routine compliance certification with no disclosed control weaknesses, fraud, or operational changes reported. Boilerplate SOX filing.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.